An investigation on behalf of investors in AngioDynamics, Inc. (NASDAQ:ANGO) shares over potential wrongdoing at AngioDynamics, Inc. was announced and NASDAQ:ANGO stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 09/29/2016 -- An investigation was announced for investors in shares of AngioDynamics, Inc. concerning potential breaches of fiduciary duties by certain AngioDynamics directors.
Investors who purchased shares of AngioDynamics, Inc. (NASDAQ:ANGO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain AngioDynamics directors breached their fiduciary duties.
AngioDynamics, Inc. reported that its Total Revenue declined from $356.53 million for the 52 weeks period that ended on May 31, 2015 to $353.89 million for the 12 months period that ended on May 31, 2016 and that its Net Loss increased over the same time periods from $3.39 millio to $43.59 million.
Shares of AngioDynamics, Inc. (NASDAQ:ANGO) grew from $10.27 per share in February 2016 to as high as $17.54 per share on September 22, 2016.
On September 28, 2106, NASDAQ:ANGO shares closed at $17.02 per share.
Those who purchased shares of AngioDynamics, Inc. have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com